Q4 2025 · 13F-HR
Sarepta Therapeutics, Inc. (SRPT)holdings as filed
Filed 2026-02-13 · accession 0001193125-26-049427
$0
Reported value
1
Positions
2025-12-31
Period end
The Brief · Sarepta Therapeutics, Inc. (SRPT) · Q4 2025
AI · grounded in 13F
Sarepta Therapeutics, Inc. SRPT maintained a static portfolio this quarter. The fund held a single position and made no additions or reductions to its holdings. Total assets under management are reported at $0.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 000000000 | — | 0 | $0 | — | 0 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.